Quantcast
Home / Columnists / Berko / Stock lacks sales, earnings to support price (access required)

Stock lacks sales, earnings to support price (access required)

DEAR MR. BERKO: In January 2014, my adviser had me buy 50 shares of Intercept Pharmaceuticals at $476, and it fell to $305 in February. In March, it began to zoom up, and my adviser had me buy 50 more shares at $422 because he thought it would go to $600. It's now down to ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

%d bloggers like this: